Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;71(11):1620-1625.
doi: 10.1111/all.12942. Epub 2016 Jul 13.

The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference

Affiliations

The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference

D M Gaunt et al. Allergy. 2016 Nov.

Abstract

Background: The Patient-Oriented Eczema Measure (POEM) has been recommended as the core patient-reported outcome measure for trials of eczema treatments. Using data from the Choice of Moisturiser for Eczema Treatment randomized feasibility study, we assess the responsiveness to change and determine the minimal clinically important difference (MCID) of the POEM in young children with eczema.

Methods: Responsiveness to change by repeated administrations of the POEM was investigated in relation to change recalled using the Parent Global Assessment (PGA) measure. Five methods of determining the MCID of the POEM were employed; three anchor-based methods using PGA as the anchor: the within-patient score change, between-patient score change and sensitivity and specificity method, and two distribution-based methods: effect size estimate and the one half standard deviation of the baseline distribution of POEM scores.

Results: Successive POEM scores were found to be responsive to change in eczema severity. The MCID of the POEM change score, in relation to a slight improvement in eczema severity as recalled by parents on the PGA, estimated by the within-patient score change (4.27), the between-patient score change (2.89) and the sensitivity and specificity method (3.00) was similar to the one half standard deviation of the POEM baseline scores (2.94) and the effect size estimate (2.50).

Conclusions: The Patient-Oriented Eczema Measure as applied to young children is responsive to change, and the MCID is around 3. This study will encourage the use of POEM and aid in determining sample size for future randomized controlled trials of treatments for eczema in young children.

Keywords: Patient-Oriented Eczema Measure; atopic eczema; minimal clinically important difference; paediatrics; responsiveness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Responsiveness of Patient‐Oriented Eczema Measure outcome measure over time compared with Parent Global Assessment (PGA). Higher positive score indicates greater improvement on both measures. PGA is an ordered categorical variable, analysed here as continuous.
Figure 2
Figure 2
Receiver operating characteristic curve of within‐patient Patient‐Oriented Eczema Measure change scores in classifying according to Parent Global Assessment subgroups of ‘better’ vs ‘no difference’.

References

    1. Weidinger S, Novak N. Atopic dermatitis. Lancet 2016;387:1109–1122. - PubMed
    1. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL et al. Guidelines of care for the management of atopic dermatitis: Part 1: diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014;70:338–351. - PMC - PubMed
    1. Schmitt J, Spuls P, Thomas K, Simpson E, Furue M, Deckert S. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol 2014;134:800–807. - PubMed
    1. Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012;67:1111–1117. - PubMed
    1. Tofte S, Graber M, Cherill R, Omoto M, Thurston M, Hanifin J. Eczema Area and Severity Index (EASI): a new tool to evaluate atopic dermatitis. J Eur Acad Dermatol Venereol 1998;11:S197. - PubMed

Publication types